Body Good Studio
GLP1 EDUCATION

Mounjaro Injections: Complete Guide to Dosing & Results

Dr. Linda Moleon, MDMay 12, 2026

What Are Mounjaro Injections?

If you've been researching medical weight loss options, you've likely encountered Mounjaro — and maybe felt overwhelmed by conflicting information about what it is, how it works, and whether it's right for you. Mounjaro injections contain tirzepatide, a once-weekly medication that acts on two hormone pathways simultaneously to reduce appetite, slow digestion, and support meaningful weight loss. Originally FDA-approved for type 2 diabetes in 2022, tirzepatide has become one of the most discussed medications in metabolic health, with many adults pursuing it off-label for weight management.

Unlike older weight loss medications, Mounjaro injections work with your body's existing hunger and satiety signals rather than stimulating the central nervous system. That makes the experience fundamentally different from appetite suppressants of the past — and it's why so many people report feeling naturally less interested in food without the jittery side effects.

This guide walks through how Mounjaro injections work, what the clinical evidence shows, how dosing is structured, what side effects to anticipate, and how to access treatment through insurance or telehealth platforms like Body Good Studio.

How Mounjaro Injections Work

Mounjaro is a dual GIP/GLP-1 receptor agonist. That means tirzepatide activates two incretin hormones:

  • GLP-1 (glucagon-like peptide-1): Slows gastric emptying, increases insulin secretion in response to food, and signals fullness to the brain.

  • GIP (glucose-dependent insulinotropic polypeptide): Enhances insulin response, influences fat metabolism, and may amplify GLP-1's effects on satiety.
  • By activating both pathways, Mounjaro injections produce stronger metabolic effects than medications that target GLP-1 alone. In clinical trials, participants using tirzepatide lost significantly more weight on average than those using semaglutide (the active ingredient in Ozempic and Wegovy).

    The medication is administered as a subcutaneous injection once weekly, typically in the abdomen, thigh, or upper arm. The injection is done with a pre-filled, single-use pen that's designed to be simple and relatively painless — most people describe it as similar to a flu shot or less uncomfortable than a fingerstick blood sugar test.

    Clinical Evidence: What the Research Shows

    Mounjaro's weight loss efficacy has been studied extensively in the SURMOUNT clinical trial program, which enrolled thousands of adults with obesity or overweight plus weight-related comorbidities.

    SURMOUNT-1 Results

    In this 72-week trial of adults without diabetes:

  • • Participants on the 5 mg dose lost an average of 15% of their body weight

  • • Those on 10 mg lost an average of 19.5%

  • • The 15 mg group lost an average of 20.9%
  • For context, that means someone starting at 240 pounds could expect to lose between 36 and 50 pounds over 18 months, depending on dose and individual response.

    SURMOUNT-2 Results

    This trial included adults with type 2 diabetes. Results were slightly lower but still clinically significant, with average weight loss ranging from 12% to 15% depending on dose.

    These results far exceed what's typically achieved with lifestyle intervention alone (around 5-7% on average) and rival outcomes from bariatric surgery in some patient populations — though surgery remains more effective for individuals with severe obesity and metabolic complications.

    If you're interested in understanding how Mounjaro compares to other GLP-1 medications in detail, you can explore more articles on the Body Good Studio blog.

    Mounjaro Dosing Schedule

    Mounjaro injections follow a structured dose escalation protocol to minimize side effects and allow your body to adjust gradually. The standard schedule looks like this:

  • Weeks 1-4: 2.5 mg once weekly

  • Weeks 5-8: 5 mg once weekly

  • Weeks 9-12: 7.5 mg once weekly

  • Weeks 13-16: 10 mg once weekly

  • Weeks 17-20: 12.5 mg once weekly

  • Week 21+: 15 mg once weekly (maximum dose)
  • Not everyone needs to reach the highest dose. Your clinician will work with you to find the minimum effective dose — the lowest amount that produces appetite control, steady weight loss, and manageable side effects. Some people achieve their goals on 5 or 7.5 mg and stay there indefinitely.

    Dosing should never be rushed. Jumping doses too quickly increases the risk of nausea, vomiting, and gastrointestinal distress — the most common reasons people discontinue GLP-1 therapy prematurely.

    For adults who want to try tirzepatide without a long-term commitment, Body Good Studio offers a tirzepatide one-time trial that lets you experience the first month of treatment before deciding whether to continue.

    Common Side Effects and How to Manage Them

    Most side effects from Mounjaro injections are gastrointestinal and dose-dependent. They typically peak within the first few days after each injection and improve as your body adjusts.

    Nausea

    The most frequently reported side effect. It's usually mild to moderate and improves over time. Strategies that help:

  • • Eat smaller, more frequent meals

  • • Avoid high-fat and greasy foods

  • • Stay hydrated throughout the day

  • • Don't lie down immediately after eating
  • If nausea becomes severe or interferes with your ability to stay on track, prescription anti-nausea medication like ondansetron can be added to your protocol. Many Body Good Studio members use it during dose increases and then taper off once they stabilize.

    Other Common Side Effects

  • Constipation or diarrhea: Usually resolves within a few weeks. Increase fiber and fluid intake.

  • Fatigue: Often related to reduced calorie intake rather than the medication itself. Prioritize protein and electrolytes.

  • Injection site reactions: Redness, swelling, or mild discomfort at the injection site. Rotate sites weekly and allow the pen to reach room temperature before injecting.
  • Rare but Serious Risks

    Tirzepatide carries a boxed warning for thyroid C-cell tumors, based on animal studies. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

    Other serious risks include pancreatitis, gallbladder disease, and severe gastrointestinal reactions. These are uncommon, but they underscore the importance of working with a licensed clinician who can screen for contraindications and monitor your progress.

    Who Is a Good Candidate for Mounjaro?

    Mounjaro injections are FDA-approved for adults with type 2 diabetes to improve blood sugar control. Many clinicians also prescribe tirzepatide off-label for weight management in adults with:

  • • A body mass index (BMI) of 30 or higher, or

  • • A BMI of 27 or higher with at least one weight-related condition (hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease)
  • You may not be a candidate if you:

  • • Are pregnant, breastfeeding, or planning to become pregnant

  • • Have a history of pancreatitis

  • • Have a personal or family history of medullary thyroid carcinoma or MEN 2

  • • Have severe gastrointestinal disease

  • • Have type 1 diabetes (tirzepatide is not a substitute for insulin)
  • A thorough new patient consultation with a licensed clinician will assess your full medical history, current medications, and treatment goals to determine whether Mounjaro or another option is the right fit.

    How to Access Mounjaro Injections

    There are two main pathways to access tirzepatide:

    Through Insurance

    If you have type 2 diabetes, Mounjaro may be covered by your insurance plan. Many commercial plans, Medicare Advantage plans, and some Medicaid programs include it on their formularies, though prior authorization is typically required.

    Body Good Studio works with patients to route prescriptions through insurance when possible. If you have diabetes and want to explore coverage, the Mounjaro through insurance program handles prior authorization and pharmacy coordination on your behalf. You can also use the free insurance probability checker to estimate your likelihood of coverage before starting.

    Compounded Tirzepatide

    For adults without diabetes — or those whose insurance doesn't cover branded Mounjaro for weight loss — compounded tirzepatide is a more affordable alternative. Compounded medications are made by licensed pharmacies using the same active ingredient as the brand-name version, but without the brand markup.

    Body Good Studio's compounded tirzepatide program includes clinician consultations, prescription management, and discreet home delivery. Pricing is transparent, and there are no surprise fees or membership gimmicks.

    What to Expect During Treatment

    Mounjaro injections are not a quick fix. Sustainable weight loss takes time, and the medication works best when combined with supportive nutrition and movement habits.

    First Month

    You'll start at the lowest dose (2.5 mg). Some people notice reduced appetite within the first week; others take a few doses to feel a difference. Weight loss during this phase is typically modest — 2 to 5 pounds is common.

    Months 2-6

    As your dose increases, appetite suppression becomes more pronounced. You may find that:

  • • You're satisfied with smaller portions

  • • Cravings for sweets or salty snacks diminish

  • • You think about food less frequently throughout the day
  • Weight loss accelerates during this period. Most people lose 1-2 pounds per week on average, though this varies widely.

    Months 6-12 and Beyond

    Weight loss continues but at a slower pace. By this point, you'll have established new eating patterns and a lower set point. Some people reach their goal weight; others continue losing. Maintenance becomes the focus — staying on the medication long-term to preserve results.

    Clinical data shows that discontinuing tirzepatide often leads to weight regain, which is why most clinicians recommend ongoing treatment for as long as it remains safe and effective.

    Why Telehealth Makes Sense for Mounjaro

    Accessing Mounjaro injections through a telehealth platform like Body Good Studio offers several advantages:

  • No in-person appointments required: Consultations, follow-ups, and prescription refills happen online.

  • Discreet home delivery: Medication ships directly to your door in unmarked packaging.

  • Licensed clinicians: Every prescription is reviewed and approved by a board-certified physician or nurse practitioner.

  • Insurance-friendly options: We help route prescriptions through your plan when possible.

  • Transparent pricing: No hidden fees, no markups, no surprise billing.
  • You also get access to ongoing support — whether that's adjusting your dose, managing side effects, or pivoting to a different medication if Mounjaro isn't working as expected. You can explore all available programs to see which structure fits your needs.

    Frequently Asked Questions

    How long does it take to see results from Mounjaro injections?

    Most people notice reduced appetite within the first 1-2 weeks, but significant weight loss typically becomes apparent after 4-8 weeks. Clinical trials show the most dramatic results occur between months 3 and 9.

    Can I stop Mounjaro injections once I reach my goal weight?

    You can, but research shows that many people regain weight after discontinuing tirzepatide. Most clinicians recommend staying on a maintenance dose long-term to preserve results, similar to how other chronic conditions are managed.

    Is Mounjaro the same as Zepbound?

    Yes — both contain tirzepatide. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved specifically for weight management. The medication and dosing are identical.

    Can I use Mounjaro if I don't have diabetes?

    Yes. While Mounjaro is FDA-approved only for diabetes, many clinicians prescribe it off-label for weight loss in adults who meet BMI and comorbidity criteria. Compounded tirzepatide is widely available for this purpose.

    What if I can't tolerate Mounjaro injections?

    If side effects are unmanageable or tirzepatide isn't effective for you, other options exist. Body Good Studio offers compounded semaglutide, oral GLP-1 medications, and non-GLP-1 options like bupropion/naltrexone for adults who can't use injectables.

    Ready to Start Your Weight Loss Journey?

    Mounjaro injections represent a meaningful shift in how we approach medical weight loss — addressing the biological drivers of hunger and metabolism rather than relying on willpower alone. Body Good Studio's clinician-prescribed programs make medical weight loss accessible, affordable, and personalized. Take our free 60-second quiz to see if you qualify — most members get a treatment plan in under 24 hours.

    Ready to get started?

    Take our quiz to find the perfect program for you.

    Take the Quiz